Pharmaceutical Waste Management Market Size, Trends and Insights By Type (Hazardous Waste, Non-Hazardous Waste), By Treatment (Incineration, Autoclaving, Chemical Treatment, Irradiative, Biological, Others), By Source (Hospitals, Pharmaceutical & Biotechnology Companies, Pharmacies), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Report Snapshot
| Study Period: | 2024-2033 |
| Fastest Growing Market: | Asia-Pacific |
| Largest Market: | Europe |
Major Players
- Stericycle Inc.
- Waste Management Inc.
- Daniels Health
- Sharps Compliance Inc.
- Clean Harbors Inc.
- Others
Reports Description
Global Pharmaceutical Waste Management Market was valued at USD 40.3 Billion in 2024 and is expected to reach USD 65.6 Billion by 2033, at a CAGR of 7.8% during the forecast period 2024 – 2033.
Pharmaceutical waste management involves the correct handling, transportation, storage, treatment, and destruction of pharmaceutical items, which may include outdated, unopened, or infected pharmaceuticals and other medical equipment.
Pharmaceutical Waste Management Market: Growth Factors
Rise in development of new drugs for various diseases
The increased discovery of new medicines for various conditions helps the pharmaceutical waste management industry grow in a variety of ways. Increased research and development efforts result in increased production volumes, which generates more waste during the production process.
Furthermore, the launch of novel therapies frequently requires the use of specialised chemicals, substances, and solvents, all of which can lead to dangerous waste streams that must be properly managed and disposed of. In addition, the disposal of expired, unused, or excess pharmaceuticals from healthcare institutions and pharmacies contributes to the overall volume of waste from pharmaceuticals.
To reduce the health and environmental risks associated with incorrect disposal, regulatory authorities are introducing tougher requirements for pharmaceutical waste management, creating the demand for specialised waste management services and customised solutions.
For instance, the Accelerating Rare Disease Cure (ARC) Programme was started by CDER in May 2022. The ARC Programme aims to use CDER’s pooled experience and initiatives to spur scientific and regulatory innovation in rare illnesses. In addition, the current trend of rapidly increasing R&D investment to sustain the high pace of new launches of specialist medications for diabetes, cancer, and autoimmune diseases.
Growing awareness campaign and stringent regulation
The pharmaceutical waste handling industry is being affected by increased awareness efforts and rigorous laws aimed at tackling the health and safety hazards associated with incorrect pharmaceutical waste disposal. The growing public knowledge of the environmental impact of drug residues in both soil and water has raised concerns among stakeholders, particularly healthcare institutions, pharmaceutical producers, and regulatory organisations.
As a result, nations worldwide are establishing stronger rules and recommendations for the correct processing, storage, and disposal of medical waste to reduce environmental contamination and preserve public health.
These standards require trash segregation, reuse and recycling, and disposal techniques that adhere to ecologically responsible practices. Environmental organisations and government agencies conduct awareness campaigns to educate stakeholders about the necessity of proper pharmaceutical waste management, which drives the need for specialized waste management services and solutions in the pharmaceutical industry.
For instance, the MWTA was a two-year federal programme under which the EPA was obligated to draft medical waste management standards. Inadvertent disposal of used needles as well as other sharps can endanger both the general public and garbage personnel. Discarded needles, for instance, might expose trash workers to needles and infection if containers burst open inside dumpsters or needles are accidentally transferred to recycling centres.
Pharmaceutical Waste Management Market: Restraints
High cost of services and transportation
The high cost of amenities and transportation creates a substantial obstacle to effective pharmaceutical waste management. To guarantee regulatory compliance and avoid environmental contamination, medical waste, especially outdated or discarded pharmaceuticals, must be handled and disposed of using specialised procedures.
However, the complexities of pharmaceutical waste, along with tight regulatory standards, frequently necessitate the use of specialised waste management services. These services incur significant expenditures for pharmaceutical waste gathering, transporting, treatment, and disposal.
In addition, pharmaceutical waste might have to be carried considerable distances to approved disposal facilities, increasing transportation costs. The expensive nature of these services and transportation may dissuade medical centres and drug companies from establishing complete waste management programmes, potentially resulting in poor disposal methods and environmental hazards.
Pharmaceutical Waste Management Market: Opportunities
Technology for effective treatment of medical waste
The biomedical waste management industry is mainly driven by technological advancements for effective medical waste treatment. An autoclave, microwaving, chemical sterilisation, and plasma gasification are all effective and ecologically acceptable ways to handle medical waste, such as expired pharmaceuticals, infected packaging, and laboratory items.
These solutions guarantee the safe disposal of pharmaceutical waste while reducing environmental contamination and the health concerns associated with incorrect disposal. Furthermore, innovations in waste tracking and management software have streamlined the tracking, segregation, and disposal processes, boosting regulatory compliance and comprehensive waste management practices in medical facilities.
As an outcome, the drug waste management market is growing, fuelled by the need for sustainable and effective solutions to address the increasing volume of medical waste created by healthcare. For instance, incineration is the controlled combustion of medical waste in a designated incinerator.
These devices are often known among industry specialists as hospital/medical/infectious waste incinerators (HMIWIs). Engineers frequently consider the predicted heat produced by combustion in the incinerator in which trash with a heating value of more than 3500 kcal/kg is handled in a pyrolysis unit, whereas garbage with a lower heating value is burnt in single-chamber incineration.
Pharmaceutical Waste Management Market: Segmentation Analysis
Global Pharmaceutical Waste Management market is segmented by type, treatment, source, and region. Based on type, the market is classified into hazardous waste and non-hazardous waste. Hazardous waste dominated the market in 2023 with a market share of 70.4% and is expected to keep its dominance during the forecast period 2024-2033.
The handling of pharmaceutical waste is heavily impacted by hazardous waste rules and practices. Drugs, whether expired, unused, or polluted, are considered hazardous waste because they can affect human health and the surroundings if not managed and disposed of appropriately. As a consequence, pharmaceutical waste management systems must adhere to stringent rules designed to safeguard public health and avoid environmental degradation.
This legal framework increases demand for specialised pharmaceutical waste management services and technology. Companies that provide solutions for the safe collection, delivery, treatment, and management of pharmaceutical waste play an important role in assuring regulatory compliance while reducing their ecological footprint.
Based on treatment, the market is classified into incineration, autoclaving, chemical treatment, irradiative, biological, and others. Incineration dominated the market in 2023 with a market share of 35.7% and is expected to keep its dominance during the forecast period 2024-2033.
Incineration is a key driver of the medical waste management industry owing to its efficiency in the secure disposal of various forms of medical waste. Pharmaceutical waste, particularly outdated prescriptions, contaminated materials, and leftover medications, cause environmental and health problems if not treated appropriately.
Incineration provides a dependable and ecologically friendly option by rapidly destroying medical waste at extreme temperatures, safely eliminating hazardous chemicals and germs while minimising pollutant emissions into the atmosphere.
Furthermore, incineration aids pharmaceutical businesses in meeting regulatory waste disposal standards while also reducing the danger of pollution in the environment. As medical production and consumption keep on rising globally, the necessity for effective and long-term waste management solutions such as incineration is likely to fuel market expansion.
Based on source, the market is classified into hospitals, pharmaceutical & biotechnology companies, and pharmacies. Hospitals dominated the market in 2023 with a market share of 41.8% and is expected to keep its dominance during the forecast period 2024-2033.
Healthcare institutions create a considerable quantity of medical waste and hazardous substances. If not adequately managed, this waste endangers both the surroundings and public health. Furthermore, hospitals must adhere to stringent legal and ecological requirements when disposing of medical waste, creating a need for specialised disposal solutions.
In addition, hospitals are gradually adopting ethical procedures and looking for cost-effective ways to efficiently manage pharmaceutical waste. As an outcome, there is an increasing need for complete pharmaceutical waste management services, such as gathering, shipping, treatment, and disposal, which is driving market expansion.
Moreover, the advent of novel technologies and solutions adapted to the healthcare sector’s specific demands adds to the continued growth of the pharmaceuticals waste management market, which is driven by hospitals.
Report Scope
| Feature of the Report | Details |
| Market Size in 2024 | USD 40.3 Billion |
| Projected Market Size in 2033 | USD 65.6 Billion |
| Market Size in 2023 | USD 38.2 Billion |
| CAGR Growth Rate | 7.8% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Type, Treatment, Source and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Pharmaceutical Waste Management Market: Regional Analysis
By region, Pharmaceutical Waste Management market is segmented into North America, Europe, Asia-Pacific, Latin America, the Middle East & Africa. North America dominated the global Pharmaceutical Waste Management market in 2023 with a market share of 39.1% and is expected to keep its dominance during the forecast period 2024-2033.
North America’s severe legislation and environmental requirements require pharmaceutical businesses, medical centres, and regulatory authorities to prioritise appropriate medical waste disposal and management.
Furthermore, growing public awareness of ecological responsibility and concerns about the effects of drug waste on habitats and human health are driving demand for appropriate waste management solutions. Also, North America’s developed drug production and healthcare sectors generate a significant amount of pharmaceutical waste, needing effective disposal and recycling technologies.
Moreover, technical developments and improvements in waste treatment technologies, together with government subsidies and measures to encourage sustainable practices, are driving the growth of the regional pharmaceutical waste disposal market.
Pharmaceutical Waste Management Market: Recent Developments
- In June 2023, Cabinet Health launched a medication bottle recycling effort. This programme tries to solve the issue of medical plastic waste.
- In February 2023, EcoSteris constructed a cutting-edge medical waste plant in Summerville, creating a unique and creative footprint in the business.
- In April 2022, Stericycle, Inc. debuted its most recent product, the SafeShield healthcare waste containers, built with an emphasis on high quality and maximised for secure storage of medical trash.
List of the prominent players in the Pharmaceutical Waste Management Market:
- Stericycle Inc.
- Waste Management Inc.
- Daniels Health
- Sharps Compliance Inc.
- Clean Harbors Inc.
- Veolia Environnement S.A.
- BioMedical Waste Solutions LLC
- Republic Services Inc.
- Suez Environnement S.A.
- Waste Connections Inc.
- BWS Incorporated
- Remondis Medison GmbH
- EnviroServ Waste Management Ltd.
- Cleanaway Waste Management Limited
- Covanta Holding Corporation
- GFL Environmental Inc.
- Tradebe Environmental Services LLC
- US Ecology Inc.
- Ecocare Environmental Services
- Grundon Waste Management Limited
- Others
These key players are adopting various growth strategies such as mergers & acquisitions, joint ventures, expansion, strategic alliances, new product launches, etc. to enhance their business operations and revenues.
The Pharmaceutical Waste Management Market is segmented as follows:
By Type
- Hazardous Waste
- Non-Hazardous Waste
By Treatment
- Incineration
- Autoclaving
- Chemical Treatment
- Irradiative
- Biological
- Others
By Source
- Hospitals
- Pharmaceutical & Biotechnology Companies
- Pharmacies
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market Research Methodology
- Chapter 2. Executive Summary
- 2.1 Global Pharmaceutical Waste Management Market, (2024 – 2033) (USD Billion)
- 2.2 Global Pharmaceutical Waste Management Market: snapshot
- Chapter 3. Global Pharmaceutical Waste Management Market – Industry Analysis
- 3.1 Pharmaceutical Waste Management Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Rise in the development of new drugs for various diseases
- 3.2.2 Growing awareness campaign and stringent regulation
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Treatment
- 3.7.3 Market Attractiveness Analysis By Source
- Chapter 4. Global Pharmaceutical Waste Management Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Pharmaceutical Waste Management Market: Company Market Share, 2023
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Pharmaceutical Waste Management Market – Type Analysis
- 5.1 Global Pharmaceutical Waste Management Market Overview: By Type
- 5.1.1 Global Pharmaceutical Waste Management Market Share, By Type, 2023 and 2033
- 5.2 Hazardous Waste
- 5.2.1 Global Pharmaceutical Waste Management Market by Hazardous Waste, 2024 – 2033 (USD Billion)
- 5.3 Hazardous Non-Hazardous Waste
- 5.3.1 Global Pharmaceutical Waste Management Market by Hazardous Non-Hazardous Waste, 2024 – 2033 (USD Billion)
- 5.1 Global Pharmaceutical Waste Management Market Overview: By Type
- Chapter 6. Global Pharmaceutical Waste Management Market – Treatment Analysis
- 6.1 Global Pharmaceutical Waste Management Market Overview: By Treatment
- 6.1.1 Global Pharmaceutical Waste Management Market Share, By Treatment, 2023 and 2033
- 6.2 Incineration
- 6.2.1 Global Pharmaceutical Waste Management Market by Incineration, 2024 – 2033 (USD Billion)
- 6.3 Autoclaving
- 6.3.1 Global Pharmaceutical Waste Management Market by Autoclaving, 2024 – 2033 (USD Billion)
- 6.4 Chemical Treatment
- 6.4.1 Global Pharmaceutical Waste Management Market by Chemical Treatment, 2024 – 2033 (USD Billion)
- 6.5 Irradiative
- 6.5.1 Global Pharmaceutical Waste Management Market by Irradiative, 2024 – 2033 (USD Billion)
- 6.6 Biological
- 6.6.1 Global Pharmaceutical Waste Management Market by Biological, 2024 – 2033 (USD Billion)
- 6.7 Others
- 6.7.1 Global Pharmaceutical Waste Management Market by Others, 2024 – 2033 (USD Billion)
- 6.1 Global Pharmaceutical Waste Management Market Overview: By Treatment
- Chapter 7. Global Pharmaceutical Waste Management Market – Source Analysis
- 7.1 Global Pharmaceutical Waste Management Market Overview: By Source
- 7.1.1 Global Pharmaceutical Waste Management Market Share, By Source, 2023 and 2033
- 7.2 Hospitals
- 7.2.1 Global Pharmaceutical Waste Management Market by Hospitals, 2024 – 2033 (USD Billion)
- 7.3 Pharmaceutical & Biotechnology Companies
- 7.3.1 Global Pharmaceutical Waste Management Market by Pharmaceutical & Biotechnology Companies, 2024 – 2033 (USD Billion)
- 7.4 Pharmacies
- 7.4.1 Global Pharmaceutical Waste Management Market by Pharmacies, 2024 – 2033 (USD Billion)
- 7.1 Global Pharmaceutical Waste Management Market Overview: By Source
- Chapter 8. Pharmaceutical Waste Management Market – Regional Analysis
- 8.1 Global Pharmaceutical Waste Management Market Regional Overview
- 8.2 Global Pharmaceutical Waste Management Market Share, by Region, 2023 & 2033 (USD Billion)
- 8.3. North America
- 8.3.1 North America Pharmaceutical Waste Management Market, 2024 – 2033 (USD Billion)
- 8.3.1.1 North America Pharmaceutical Waste Management Market, by Country, 2024 – 2033 (USD Billion)
- 8.3.1 North America Pharmaceutical Waste Management Market, 2024 – 2033 (USD Billion)
- 8.4 North America Pharmaceutical Waste Management Market, by Type, 2024 – 2033
- 8.4.1 North America Pharmaceutical Waste Management Market, by Type, 2024 – 2033 (USD Billion)
- 8.5 North America Pharmaceutical Waste Management Market, by Treatment, 2024 – 2033
- 8.5.1 North America Pharmaceutical Waste Management Market, by Treatment, 2024 – 2033 (USD Billion)
- 8.6 North America Pharmaceutical Waste Management Market, by Source, 2024 – 2033
- 8.6.1 North America Pharmaceutical Waste Management Market, by Source, 2024 – 2033 (USD Billion)
- 8.7. Europe
- 8.7.1 Europe Pharmaceutical Waste Management Market, 2024 – 2033 (USD Billion)
- 8.7.1.1 Europe Pharmaceutical Waste Management Market, by Country, 2024 – 2033 (USD Billion)
- 8.7.1 Europe Pharmaceutical Waste Management Market, 2024 – 2033 (USD Billion)
- 8.8 Europe Pharmaceutical Waste Management Market, by Type, 2024 – 2033
- 8.8.1 Europe Pharmaceutical Waste Management Market, by Type, 2024 – 2033 (USD Billion)
- 8.9 Europe Pharmaceutical Waste Management Market, by Treatment, 2024 – 2033
- 8.9.1 Europe Pharmaceutical Waste Management Market, by Treatment, 2024 – 2033 (USD Billion)
- 8.10 Europe Pharmaceutical Waste Management Market, by Source, 2024 – 2033
- 8.10.1 Europe Pharmaceutical Waste Management Market, by Source, 2024 – 2033 (USD Billion)
- 8.11. Asia Pacific
- 8.11.1 Asia Pacific Pharmaceutical Waste Management Market, 2024 – 2033 (USD Billion)
- 8.11.1.1 Asia Pacific Pharmaceutical Waste Management Market, by Country, 2024 – 2033 (USD Billion)
- 8.11.1 Asia Pacific Pharmaceutical Waste Management Market, 2024 – 2033 (USD Billion)
- 8.12 Asia Pacific Pharmaceutical Waste Management Market, by Type, 2024 – 2033
- 8.12.1 Asia Pacific Pharmaceutical Waste Management Market, by Type, 2024 – 2033 (USD Billion)
- 8.13 Asia Pacific Pharmaceutical Waste Management Market, by Treatment, 2024 – 2033
- 8.13.1 Asia Pacific Pharmaceutical Waste Management Market, by Treatment, 2024 – 2033 (USD Billion)
- 8.14 Asia Pacific Pharmaceutical Waste Management Market, by Source, 2024 – 2033
- 8.14.1 Asia Pacific Pharmaceutical Waste Management Market, by Source, 2024 – 2033 (USD Billion)
- 8.15. Latin America
- 8.15.1 Latin America Pharmaceutical Waste Management Market, 2024 – 2033 (USD Billion)
- 8.15.1.1 Latin America Pharmaceutical Waste Management Market, by Country, 2024 – 2033 (USD Billion)
- 8.15.1 Latin America Pharmaceutical Waste Management Market, 2024 – 2033 (USD Billion)
- 8.16 Latin America Pharmaceutical Waste Management Market, by Type, 2024 – 2033
- 8.16.1 Latin America Pharmaceutical Waste Management Market, by Type, 2024 – 2033 (USD Billion)
- 8.17 Latin America Pharmaceutical Waste Management Market, by Treatment, 2024 – 2033
- 8.17.1 Latin America Pharmaceutical Waste Management Market, by Treatment, 2024 – 2033 (USD Billion)
- 8.18 Latin America Pharmaceutical Waste Management Market, by Source, 2024 – 2033
- 8.18.1 Latin America Pharmaceutical Waste Management Market, by Source, 2024 – 2033 (USD Billion)
- 8.19. The Middle-East and Africa
- 8.19.1 The Middle-East and Africa Pharmaceutical Waste Management Market, 2024 – 2033 (USD Billion)
- 8.19.1.1 The Middle-East and Africa Pharmaceutical Waste Management Market, by Country, 2024 – 2033 (USD Billion)
- 8.19.1 The Middle-East and Africa Pharmaceutical Waste Management Market, 2024 – 2033 (USD Billion)
- 8.20 The Middle-East and Africa Pharmaceutical Waste Management Market, by Type, 2024 – 2033
- 8.20.1 The Middle-East and Africa Pharmaceutical Waste Management Market, by Type, 2024 – 2033 (USD Billion)
- 8.21 The Middle-East and Africa Pharmaceutical Waste Management Market, by Treatment, 2024 – 2033
- 8.21.1 The Middle-East and Africa Pharmaceutical Waste Management Market, by Treatment, 2024 – 2033 (USD Billion)
- 8.22 The Middle-East and Africa Pharmaceutical Waste Management Market, by Source, 2024 – 2033
- 8.22.1 The Middle-East and Africa Pharmaceutical Waste Management Market, by Source, 2024 – 2033 (USD Billion)
- Chapter 9. Company Profiles
- 9.1 Stericycle Inc.
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 Waste Management Inc.
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Daniels Health
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 Sharps Compliance Inc.
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Clean Harbors Inc.
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Veolia Environnement S.A.
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 BioMedical Waste Solutions LLC
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Republic Services Inc.
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Suez Environnement S.A.
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 Waste Connections Inc.
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 BWS Incorporated
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 Remondis Medison GmbH
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 EnviroServ Waste Management Ltd.
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 Cleanaway Waste Management Limited
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 Covanta Holding Corporation
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 GFL Environmental Inc.
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.17 Tradebe Environmental Services LLC
- 9.17.1 Overview
- 9.17.2 Financials
- 9.17.3 Product Portfolio
- 9.17.4 Business Strategy
- 9.17.5 Recent Developments
- 9.18 US Ecology Inc.
- 9.18.1 Overview
- 9.18.2 Financials
- 9.18.3 Product Portfolio
- 9.18.4 Business Strategy
- 9.18.5 Recent Developments
- 9.19 Ecocare Environmental Services
- 9.19.1 Overview
- 9.19.2 Financials
- 9.19.3 Product Portfolio
- 9.19.4 Business Strategy
- 9.19.5 Recent Developments
- 9.20 Grundon Waste Management Limited
- 9.20.1 Overview
- 9.20.2 Financials
- 9.20.3 Product Portfolio
- 9.20.4 Business Strategy
- 9.20.5 Recent Developments
- 9.21 Others.
- 9.21.1 Overview
- 9.21.2 Financials
- 9.21.3 Product Portfolio
- 9.21.4 Business Strategy
- 9.21.5 Recent Developments
- 9.1 Stericycle Inc.
List Of Figures
Figures No 1 to 27
List Of Tables
Tables No 1 to 77
Report Methodology
In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:
Preliminary Data Mining
On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.
Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.
Statistical Model
Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.
Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.
Some of the variables taken into account for forecasting are as follows:
• Industry drivers and constraints, as well as their current and projected impact
• The raw material case, as well as supply-versus-price trends
• Current volume and projected volume growth through 2033
We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.
Primary Validation
This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.
Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.
All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:
• Market leaders
• Suppliers of raw materials
• Suppliers of raw materials
• Buyers.
The following are the primary research objectives:
• To ensure the accuracy and acceptability of our data.
• Gaining an understanding of the current market and future projections.
Data Collection Matrix
| Perspective | Primary research | Secondary research |
| Supply-side |
|
|
| Demand-side |
|
|
Market Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|
|
Prominent Player
- Stericycle Inc.
- Waste Management Inc.
- Daniels Health
- Sharps Compliance Inc.
- Clean Harbors Inc.
- Veolia Environnement S.A.
- BioMedical Waste Solutions LLC
- Republic Services Inc.
- Suez Environnement S.A.
- Waste Connections Inc.
- BWS Incorporated
- Remondis Medison GmbH
- EnviroServ Waste Management Ltd.
- Cleanaway Waste Management Limited
- Covanta Holding Corporation
- GFL Environmental Inc.
- Tradebe Environmental Services LLC
- US Ecology Inc.
- Ecocare Environmental Services
- Grundon Waste Management Limited
- Others
FAQs
The restraints of the Pharmaceutical Waste Management market is high cost of services and transportation.
The major driver for the Pharmaceutical Waste Management market is rise in development of new drugs for various diseases and growing awareness campaign and stringent regulation.
The “Hazardous Waste” category dominated the market in 2023.
The key players in the market are Stericycle Inc., Waste Management Inc., Daniels Health, Sharps Compliance Inc., Clean Harbors Inc., Veolia Environnement S.A., BioMedical Waste Solutions LLC, Republic Services Inc., Suez Environnement S.A., Waste Connections Inc., BWS Incorporated, Remondis Medison GmbH, EnviroServ Waste Management Ltd., Cleanaway Waste Management Limited, Covanta Holding Corporation, GFL Environmental Inc., Tradebe Environmental Services LLC, US Ecology Inc., Ecocare Environmental Services, Grundon Waste Management Limited, Others.
“North America” had the largest share in the Pharmaceutical Waste Management Market.
The global market is projected to grow at a CAGR of 7.8% during the forecast period, 2024-2033.
The Pharmaceutical Waste Management Market size was valued at USD 40.3 Billion in 2024.